Clinical Trial Update: The Effect of Bevacizumab on the Trabeculectomy [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on the phase 2/3 study evaluating bevacizumab's effect on trabeculectomy outcomes in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Glaucoma | Phase 2, Phase 3 | Status: UNKNOWN